Citadel Advisors
HCAT icon

Citadel Advisors’s Health Catalyst HCAT Stock Holding History

Citadel Advisors’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69K Buy
+54,300
New +$102K ﹤0.01% 12259
2025
Q2 		– Sell
-5,800
Closed -$26.3K – 13527
2025
Q1 		$26.3K Buy
5,800
+5,000
+625% +$26.5K ﹤0.01% 12931
2024
Q4 		$5.66K Sell
800
-5,600
-88% -$44.6K ﹤0.01% 13846
2024
Q3 		$52.1K Buy
6,400
+4,600
+256% +$33.2K ﹤0.01% 11862
2024
Q2 		$11.5K Sell
1,800
-9,000
-83% -$57.8K ﹤0.01% 13031
2024
Q1 		$81.3K Buy
10,800
+10,100
+1,443% +$92.2K ﹤0.01% 11633
2023
Q4 		$6.48K Sell
700
-15,500
-96% -$127K ﹤0.01% 13347
2023
Q3 		$164K Buy
16,200
+9,300
+135% +$111K ﹤0.01% 10214
2023
Q2 		$86.3K Buy
6,900
+4,100
+146% +$48.8K ﹤0.01% 11145
2023
Q1 		$32.7K Sell
2,800
-1,000
-26% -$12.7K ﹤0.01% 12648
2022
Q4 		$40.4K Sell
3,800
-15,100
-80% -$146K ﹤0.01% 12409
2022
Q3 		$183K Buy
+18,900
New +$250K ﹤0.01% 10492
2022
Q1 		– Sell
-9,500
Closed -$376K – 13984
2021
Q4 		$376K Sell
9,500
-4,700
-33% -$214K ﹤0.01% 10388
2021
Q3 		$710K Buy
14,200
+3,300
+30% +$180K ﹤0.01% 9033
2021
Q2 		$605K Buy
+10,900
New +$581K ﹤0.01% 9600
2021
Q1 		– Sell
-12,600
Closed -$548K – 13385
2020
Q4 		$548K Sell
12,600
-18,900
-60% -$697K ﹤0.01% 7962
2020
Q3 		$1.15M Buy
+31,500
New +$1.07M ﹤0.01% 5772

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors's HCAT Position: Q3 2025 in Review

Citadel Advisors sold out of Health Catalyst (HCAT) in Q3 2025, closing a stake of 57,426 shares — an estimated $216K sold.

Citadel Advisors first reported a position in HCAT in Q3 2019 and held it in 23 quarters. The position peaked at $12.4M in Q1 2022. 145 funds tracked by Wall St. Rank hold HCAT as of Q3 2025.

  • Citadel Advisors reported no remaining Health Catalyst position as of Q3 2025 after selling out during the quarter.
  • Citadel Advisors sold 57,426 Health Catalyst shares in Q3 2025, an estimated $216K.
  • Citadel Advisors first reported a position in Health Catalyst in Q3 2019 and held it in 23 quarters.
  • Citadel Advisors's Health Catalyst position peaked at $12.4M in Q1 2022.
  • 145 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.